The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases)
about
IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) familyRBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradationNF-kappaB activator Act1 associates with IL-1/Toll pathway adaptor molecule TRAF6Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complexReceptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6Interleukin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathwayActivation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunitRecruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory proteinOsteoimmunology: interactions of the bone and immune systemRequirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transductionCLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-kappaB activation and apoptosisTIRP, a novel Toll/interleukin-1 receptor (TIR) domain-containing adapter protein involved in TIR signalingRas participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKsThe IL1 receptor accessory protein is responsible for the recruitment of the interleukin-1 receptor associated kinase to the IL1/IL1 receptor I complexInterleukin-1beta activates a short STAT-3 isoform in clonal insulin-secreting cellsThe cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-kappaB activation at the level of TRAF6TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signalingIL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cellsIdentification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signalingInterleukin (IL)-1 and IL-6 regulation of neural progenitor cell proliferation with hippocampal injury: differential regulatory pathways in the subgranular zone (SGZ) of the adolescent and mature mouse brain.Gene targeting in the analysis of mammalian apoptosis and TNF receptor superfamily signaling.Activation of MyD88 signaling upon staphylococcal enterotoxin binding to MHC class II moleculesThe IL-1 receptor and Rho directly associate to drive cell activation in inflammation.A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activityMutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase.Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction.Importance of interleukin-1 and interleukin-1 receptor antagonist in short-term glucose sensor function in vivo.Toll receptors: a central element in innate immune responsesIL1RAP as a surface marker for leukemia stem cells is related to clinical phase of chronic myeloid leukemia patients.IL-1 beta signalling in glial cells in wildtype and IL-1RI deficient miceInterleukin-18 and host defense against infection.A single-nucleotide polymorphism in the interleukin-1 receptor-associated protein gene is associated with impaired glucose regulation and type 2 diabetes in a case-controlled study.Chronic inflammation in cancer development.Interleukin-1R3 mediates interleukin-1-induced potassium current increase through fast activation of Akt kinase.The E3 ubiquitin ligase MARCH8 negatively regulates IL-1β-induced NF-κB activation by targeting the IL1RAP coreceptor for ubiquitination and degradation.Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 productionNew findings in osteoarthritis pathogenesis: therapeutic implications.Cell signalling in macrophages, the principal innate immune effector cells of rheumatoid arthritis.
P2860
Q22010176-9AEF2A2C-90E4-48FE-962B-BBD2D7914E6EQ24303616-8A17D028-44FB-420C-9620-4CB66DEF1907Q24322734-02CBDAEC-1CC3-4FC5-9824-FE8F68B4F333Q24337456-97612A8F-8713-480A-AD8D-01BE7CC2034DQ24537518-636F8BDD-22EA-43AA-835F-716FEA8E6F7FQ24550984-04D82EC6-4137-490B-9108-E2B63D7948FDQ24554482-83B98894-3B1C-48CE-BF31-C7E1FAB111DBQ24642310-110216A1-A588-49B7-91F8-512999C0D23FQ24655113-7C5160C3-85C2-4FCE-998F-86874A3E0665Q24676400-01EDA0A4-DE23-47A5-9E84-44D2BA0A8221Q28199393-0874C1B5-34DF-4F16-AFF5-083D78885402Q28201815-9C843ACB-82FE-4449-9C85-35FA203FC248Q28211306-A14DFD8A-0A3B-49F1-9490-70479A83C448Q28239808-2C615A4D-285A-455B-97F6-AEE852465D2EQ28258676-8241B518-D5CC-4F67-A73C-40475B207344Q28295615-41E4AB37-7A62-4B52-BFD8-3DCA75D6BD3FQ28296101-BAA53388-1360-47B8-8875-A202EF1F0B49Q28513445-27A783A4-C2B0-471F-A626-D8308E1872BAQ28513686-3ECF809A-76C1-41E8-A923-6350AC288AFDQ28592094-934C074E-7656-4DC7-93AF-2CA9986EEA1AQ33690316-194CAAEB-F5AD-4D9D-AFD0-42FFEB32A123Q33713375-2CD449E4-68A8-4EF1-B218-36966DE1CA98Q33809237-4586E3DC-A811-4F3F-9F9E-2A85ACEC9823Q33852530-67743ADE-AF84-4658-ABF2-A2B9CBB53877Q33921027-27A92A9E-3E12-48EB-9E4F-3407DA4B217BQ33957447-3C1A4EBE-F5AD-4A98-A234-A440891F1EFCQ33958468-404F2AD7-DC8B-4455-864B-E3E95580B0B4Q34153275-FBE9104E-EC0B-4B52-AE34-B606EB400FB2Q34209078-87619507-FFCE-42EB-B22E-84A5223BE246Q34537817-3FD24745-722F-49EC-96C5-61A32B52EB2CQ35016953-6040CE07-A149-45C9-AEC2-7259D28B80EFQ35044365-748ECDF9-16A7-4D16-B63D-DB605943B193Q35147841-F4162C72-85E2-4CA4-8C2E-3B3C47B61BB1Q35803472-32BE378C-BCFF-40E8-835E-D336572A5FA8Q35928265-518C8B11-0E2A-4E67-B499-E4EDE1D0FFBFQ36132847-10D7037F-1B1C-48D7-A19E-4CEDBD88FEE5Q36212969-EB46B55A-9569-45C7-BF88-A683696BCD3CQ36401139-3C68622D-E935-4802-97EF-CBD806F89CF8Q36515489-14F6041F-B9D6-4DC6-B3C5-5D4D3FED633AQ36993214-6C1079A3-9E9A-48E5-B222-0C49294EF46A
P2860
The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases)
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
The interleukin-1 receptor acc ...... protein kinases (SAP kinases)
@ast
The interleukin-1 receptor acc ...... protein kinases (SAP kinases)
@en
The interleukin-1 receptor acc ...... protein kinases (SAP kinases)
@en-gb
The interleukin-1 receptor acc ...... protein kinases (SAP kinases)
@nl
type
label
The interleukin-1 receptor acc ...... protein kinases (SAP kinases)
@ast
The interleukin-1 receptor acc ...... protein kinases (SAP kinases)
@en
The interleukin-1 receptor acc ...... protein kinases (SAP kinases)
@en-gb
The interleukin-1 receptor acc ...... protein kinases (SAP kinases)
@nl
prefLabel
The interleukin-1 receptor acc ...... protein kinases (SAP kinases)
@ast
The interleukin-1 receptor acc ...... protein kinases (SAP kinases)
@en
The interleukin-1 receptor acc ...... protein kinases (SAP kinases)
@en-gb
The interleukin-1 receptor acc ...... protein kinases (SAP kinases)
@nl
P2093
P921
P356
P1476
The interleukin-1 receptor acc ...... protein kinases (SAP kinases)
@en
P2093
P304
P356
10.1074/JBC.272.12.7727
P407
P577
1997-03-21T00:00:00Z